MRK
HEALTHCAREMerck & Co Inc
$113.56+0.41 (+0.36%)PRE
Live · NYSE · May 8, Close
AI Insight
What's Moving MRK Today?
No stock-specific AI insight has been generated for MRK yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$70.74$124.22
$113.56
Fundamentals
Market Cap$280.5B
P/E Ratio32.0
EPS$3.55
Dividend Yield0.03%
Dividend / Share$3.28
ROE0.2%
Profit Margin0.1%
Debt / Equity—
Trading
Volume7.3M
Avg Volume (10D)—
Shares Outstanding2.47B
MRK News
61 articles- Merck & Co., Inc. (NYSE:MRK) Given Consensus Rating of "Moderate Buy" by BrokeragesMarketBeat·May 9, 2026
- Crossmark Global Holdings Inc. Has $24.83 Million Stock Position in Merck & Co., Inc. $MRKMarketBeat·May 9, 2026
- Merck & Co., Inc. stock (US58933Y1055): Earnings and pipeline updates drive investor focusAD HOC NEWS·May 9, 2026
- How Hantavirus Made Moderna a Must-Own Stock AgainYahoo Finance·May 8, 2026
- Merck Faces Gardasil Trial After $8.9 Billion Sales PeakYahoo Finance·May 8, 2026
- 2 Dividend Stocks to Double Up On Right NowMotley Fool·May 8, 2026
- Violich Capital Management Inc. Has $5.29 Million Stock Position in Merck & Co., Inc. $MRKMarketBeat·May 8, 2026
- Codexis, Inc. Q1 2026 Earnings Call SummaryMoby·May 8, 2026
- A $1.5 Million Portfolio That Quietly Pays You $83,400 a Year, No Job Required247 Wall St·May 8, 2026
- Merck & Co., Inc. stock (US58933Y1055): Earnings, pipeline and US market roleAd Hoc News·May 8, 2026
- 3 Stocks That Could Be Trading Up To 46.1% Below Their Estimated Intrinsic ValueYahoo Finance·May 8, 2026
- Federation of American Hospitals taps new government relations headHealthcaredive·May 8, 2026
- Generali Asset Management SPA SGR Sells 32,367 Shares of Merck & Co., Inc. $MRKMarketBeat·May 8, 2026
- The Agencies Building Pharma's Next Decade Just Picked Their Software: Daily Command Launches With 18 of the Industry's Most Senior Agency Leaders Already Inside ItYahoo Finance·May 7, 2026
- Codexis Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- Vanguard High Dividend Yield ETF Delivers 67% Five-Year Returns Against Schwab U.S. Dividend Equity ETF’s Steadier 229% Decade Gain247 Wall St·May 7, 2026
- 75 of Pharma's Most Senior Marketers Just Walked Away From a $12 Billion Tool StackYahoo Finance·May 7, 2026
- Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide DecanoateBusiness Wire·May 7, 2026
- Eli Lilly Now Has the World's Best-Selling Drug -- But Does That Make the Stock a No-Brainer Buy?Motley Fool·May 7, 2026
- Darzalex, Erleada & New Drugs Keep J&J's Oncology Engine Charged in Q1Yahoo Finance·May 7, 2026
- AIM ImmunoTech Announces 50% Objective Response Rate (ORR) in UPMC Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination PotentialYahoo Finance·May 7, 2026
- Premier Fund Managers Ltd Takes Position in Merck & Co., Inc. $MRKMarketBeat·May 7, 2026
- Merck Becomes Sole Testing Provider for Genetix Biotherapeutics’ FDA-Approved Gene TherapiesYahoo Finance·May 7, 2026
- Merck & Co., Inc. $MRK Shares Acquired by Lmcg Investments LLCMarketBeat·May 7, 2026
- Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by K.J. Harrison & Partners IncMarketBeat·May 7, 2026
- Salesforce AI Win With Merck Highlights Real World Platform AdoptionYahoo Finance·May 7, 2026
- Analyst Raises Merck (MRK) Price Target by $1 After Beating Q1 EstimatesYahoo Finance·May 6, 2026
- EXEL Q1 Earnings Top Estimates, Colorectal Cancer Drug in FocusYahoo Finance·May 6, 2026
- 6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash247 Wall St·May 6, 2026
- InVitria Showcases Exbumin® and Optibumin® 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved BiologicsGlobeNewswire Inc.·May 1, 2026
- Bulk Filtration Market Report 2026, Competitive Analysis of 3M, Eaton, Parker-Hannifin, Pentair, Merck, Danaher, Mann+Hummel - Analyst Recommendations and Global Forecast to 2031GlobeNewswire Inc.·Apr 28, 2026
- Antibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor IntelligenceGlobeNewswire Inc.·Apr 28, 2026
- Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash DealThe Motley Fool·Apr 27, 2026
- AI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive InnovationGlobeNewswire Inc.·Apr 27, 2026
- Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsightGlobeNewswire Inc.·Apr 27, 2026
- Mental Health Clinical Trials Research Report 2026: $4.89 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FGlobeNewswire Inc.·Apr 24, 2026
- Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsightGlobeNewswire Inc.·Apr 22, 2026
- Vulvar Cancer Market Global and Regional Analysis Report 2025-2035, Profiles of Merck & Co., Bristol Myers Squibb, and AstraZenecaGlobeNewswire Inc.·Apr 22, 2026
- Why Is Merck Stock Falling Tuesday?Benzinga·Apr 21, 2026
Price Data
Open$113.15
Previous Close$113.15
Day High$114.49
Day Low$112.96
52 Week High$124.22
52 Week Low$70.74
52-Week Range
$70.74$124.22
$113.56
Fundamentals
Market Cap$280.5B
P/E Ratio32.0
EPS$3.55
Dividend Yield0.03%
Dividend / Share$3.28
ROE0.2%
Profit Margin0.1%
Debt / Equity—
Trading
Volume7.3M
Avg Volume (10D)—
Shares Outstanding2.47B
About Merck & Co Inc
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
HEALTHCAREDRUG MANUFACTURERS - GENERAL
Company Details
Security TypeStock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - GENERAL
CIK—
Composite FIGI—
Share Class FIGI—